Articles related to Paul MacDonald

The latest CEO appointment at the helm of Pathfinder has a med-devices background.

UPDATED 12:44 p.m.Nationwide search lands med-devices veteran for persistent Vanderbilt spin-out

Venture continues to scout capital, relying on federal grants to stay alive and hoping for a break

Making scientific discoveries that can survive the punishing path toward the market is hard enough. Now that the FDA has approved marketing that could save liver-cancer patients' lives, Pathfinder Therapeutics hopes local investors and the State of Tennessee can lend a hand. But, they're not holding their breath.